Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | NCEH1 | Q6PIU2 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | ADK | P55263 | 1/20 | 0.41 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7666433 | 0.87 | NCEH1 (0.43) | SMN1; SMN2KDM4EALDH1A1NCEH1HTT | |
| SCHEMBL8035953 | 0.86 | ALDH1A1 (0.45) | KDM4EALDH1A1HTTMAPTTP53 | |
| SCHEMBL29733218 | 0.84 | NCEH1 (0.42) | SMN1; SMN2ALDH1A1NCEH1MAPTSLC2A1 | |
| SCHEMBL9514367 | 0.84 | GAA (0.44) | HTTGAA | |
| SCHEMBL28518796 | 0.83 | THRB (0.45) | SMN1; SMN2NCEH1MAPTSLC2A1NPC1 | |
| SCHEMBL9517997 | 0.81 | L3MBTL1 (0.46) | SMN1; SMN2KDM4EALDH1A1MAPTSLC2A1 | |
| SCHEMBL3379051 | 0.81 | SLC2A1 (0.46) | ALDH1A1NCEH1HSD17B10SLC2A1 | |
| SCHEMBL8763678 | 0.80 | SLC2A1 (0.44) | ALDH1A1NCEH1MAPTHSD17B10SLC2A1 | |
| SCHEMBL27867868 | 0.80 | G6PD (0.41) | SLC2A1BACE1 | |
| SCHEMBL5675873 | 0.79 | KDM4E (0.54) | KDM4EALDH1A1HTTMAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1370221-A2 | METHOD AND COMPOSITION FOR THE GRADUAL PERMANENT COLORING OF HAIR | UNILEVER PLC (GB) | 2003-12-17 | — | — | EP | claimed |
| WO-2002074266-A2 | METHOD AND COMPOSITION FOR THE GRADUAL PERMANENT COLORING OF HAIR | UNILEVER PLC (GB) | 2002-09-26 | — | — | WO | claimed |
| EP-3556211-B1 | ORGANIC AMMONIUM SALTS OF ANIONIC PESTICIDES | CLARIANT INT LTD (CH) | 2023-01-25 | — | — | EP | disclosed |
| US-20170339949-A1 | SUGAR SURFACTANTS AND USE THEREOF IN AGROCHEMICAL COMPOSITIONS | CLARIANT INTERNATIONAL LTD. (CH) | 2017-11-30 | — | — | US | disclosed |
| US-20170231223-A1 | Organic Ammonium Salts Of Anionic Pesticides | CLARIANT INTERNATIONAL LTD. (CH) | 2017-08-17 | — | — | US | disclosed |
| US-20170055524-A1 | Aqueous Adjuvant Composition For Increasing The Efficacy Of Electrolyte Active Substances | CLARIANT INTERNATIONAL LTD. (CH) | 2017-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170339949-A1 | SUGAR SURFACTANTS AND USE THEREOF IN AGROCHEMICAL COMPOSITIONS | SGMS1, DEGS1, SGMS2 | SMN1; SMN2 3159/4885KDM4E 3660/4885ALDH1A1 845/4885 |
| US-20170231223-A1 | Organic Ammonium Salts Of Anionic Pesticides | HCN3, HCN4, KCNH3 | SMN1; SMN2 4205/4885KDM4E 907/4885ALDH1A1 1723/4885 |
| US-20170055524-A1 | Aqueous Adjuvant Composition For Increasing The Efficacy Of Electrolyte Active Substances | ASNS, ARG1, PHOSPHO1 | SMN1; SMN2 3144/4885KDM4E 4507/4885ALDH1A1 3347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.